arrow
I

Inga-Marie Schaefer

brigham and women s hospital
H指数:34
被引数:4,491

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma

共靶向CDK2和CDK9抑制MYC致癌程序,并在CIC重排肉瘤中具有抗肿瘤作用

2026-10-070
OA
Low-grade fi bromyxoid sarcoma and sclerosing epithelioid fi brosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
2024-09-010
OAAI
Multi-omics evaluation of TFE3-fusions and potential association with immuno-metabolic vulnerabilities in alveolar soft part sarcoma (ASPS) and translocation-positive renal cell carcinoma (tRCC)
2023-10-010
PRE
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
2023-01-0122
OAAI
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments

超罕见肉瘤的回顾性观察性研究: 结缔组织肿瘤学会 (CTOS) 专家社区关于评估全身治疗活动的最低要求的共识论文

2022-11-0116
OAAI
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST
2022-09-2915
OA
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
CANCER
IF5.1
2021-04-28126
OAAI
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
2020-11-01103
OAAI